Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

512
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
512
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

165
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
165
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

772
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
772
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

889
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
889
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

907
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
907

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambient temperature variations and antimicrobial resistance: a multicountry analysis of non-linear relationships and temperature thresholds.

BMJ global health·2026
Same author

Total treatment interval and quality of life of women living with breast cancer in Ethiopia: the mediating role of financial toxicity.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Association between time to treatment and financial toxicity among women with breast cancer in Ethiopia: a multicentre study in a low-resource setting.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

LsMAPK6 Phosphorylates the LsCO Protein to Enhance Its Stability and Transcriptional Activity, Promoting Floral Transition Upon High Temperatures in Lettuce.

Plant biotechnology journal·2026
Same author

Temporal dynamics of ferroptosis markers and neuroprotective intervention in cerebral ischemia-reperfusion injury: Insights for therapeutic strategy development.

Iranian journal of basic medical sciences·2026
Same author

Climate change and antimicrobial resistance in the Western Pacific: a mixed-methods systematic analysis.

The Lancet regional health. Western Pacific·2026

Related Experiment Video

Updated: Dec 11, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K

Understanding consumer behavior patterns in antibiotic usage for upper respiratory tract infections: A study protocol

Zhonghong Duan1, Chaojie Liu2, Meng Han1

  • 1School of Medicine and Health Management, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Research in Social & Administrative Pharmacy : RSAP
|August 25, 2020
PubMed
Summary

Understanding consumer behavior in antibiotic use for upper respiratory tract infections (URTIs) is crucial. This study identifies distinct patterns to inform targeted interventions for irrational antibiotic use.

Keywords:
COM-BChinaCross-sectional surveyLatent class analysisRational use of antibiotics

More Related Videos

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
06:18

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Published on: December 14, 2020

3.8K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.0K

Related Experiment Videos

Last Updated: Dec 11, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K
Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
06:18

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Published on: December 14, 2020

3.8K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.0K

Area of Science:

  • Public Health
  • Behavioral Science
  • Pharmaceutical Sciences

Background:

  • Irrational antibiotic use is a global issue, yet consumer behavior insights remain limited.
  • Understanding consumer decision-making for antibiotic use in upper respiratory tract infections (URTIs) is essential for public health.
  • This research addresses the gap in knowledge regarding consumer behaviors related to antibiotic consumption for URTIs.

Purpose of the Study:

  • To identify and categorize distinct consumer behavior patterns associated with antibiotic use for URTIs.
  • To develop a classification system for consumer behaviors to enable targeted public health interventions.
  • To elucidate the underlying mechanisms influencing diverse consumer behavior patterns using the COM-B model.

Main Methods:

  • A mixed-methods approach integrating the Capacity, Opportunity, Motivation-Behavior (COM-B) framework.
  • Systematic literature review for COM-B attribute extraction, followed by semi-structured interviews with URTI patients.
  • Instrument validation via Delphi consultations and surveys, culminating in a large-scale cross-sectional survey in China with multi-level latent class and multinomial regression analyses.

Main Results:

  • Classification of consumers into distinct behavioral pattern categories based on antibiotic purchasing, consumption, and disposal for URTIs.
  • Identification of key behavioral features including need recognition, information seeking, alternative assessment, purchase, use, and post-use evaluation.
  • Determination of predictors influencing different consumer behavior patterns towards antibiotic use for URTIs.

Conclusions:

  • The study successfully categorizes consumer behaviors related to antibiotic use for URTIs, providing a foundation for targeted interventions.
  • The COM-B model offers valuable insights into the psychological and environmental drivers of these behaviors.
  • Findings support the development of evidence-based strategies to combat irrational antibiotic use and improve antimicrobial stewardship.